Publications & Resources
Get insights and guidance from MLMIC and other leading sources on medical professional liability, risk management, and more.
Tag: medications
Risk Management Tip: Managing Drug Seeking Patients
Healthcare professionals share in the responsibility for minimizing prescription drug abuse and drug diversion. Physicians are tasked with differentiating patients in need of effective pain management from those who may be seeking drugs for inappropriate reasons. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.
FDA Approves Veklury for Treatment of COVID-19 Patients Who Meet Certain Criteria
The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.
FDA Warns About Illicit Online Opioid Retailers
The FDA cautions that a number of websites are illegally selling unauthorized opioids that may be counterfeit, contaminated, expired or otherwise unsafe.
How to Prevent Medication Errors When Faced With the Pressures of Pandemic Care
The hectic pace of pandemic care may contribute to medication errors. It’s critical to recognize this risk by putting into place safeguards that support identifying and preventing these errors.
Risk Management Tip: Managing Patients with Chronic Pain
The management of chronic pain through the prescription of controlled medication poses challenges and risks to both the patient and the healthcare provider. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.
Risk Management Tip: Managing Medication Samples
Medication samples are widely used in a physician’s office practice. A standard process should be in place for the proper handling, storage, dispensing, and disposal of medication samples. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.
“Expression of Concern” Issued About Data Cited in Two Major COVID-19 Studies
Recent statements issued by the New England Journal of Medicine and the Lancet share significant concern related to the credibility of two major studies evaluating the safety and efficacy of hydroxychloroquine to prevent and treat COVID-19.
MLMIC Launches Podcast with Guidance for Reopening Medical Practices
To support policyholders as they resume operations, MLMIC has recorded a podcast with recommendations and key considerations for safely and effectively reopening.
Healthcare Providers Are Reminded to Use Caution When Prescribing Antibiotics During the Pandemic
A news report issued by the University of Minnesota’s Center for Infectious Disease Research and Policy shares concern related to extensive use of antibiotics to treat COVID-19, a practice that may be accelerating antibiotic resistance.
Risk Management Checklists: Medication Management
MLMIC encourages policyholders to review these important Risk Management Checklists on medication management, including guidance on how to manage medication samples and how to promote patient adherence to a medication regimen.